Neisseria gonorrhoeae and Mycoplasma genitalium

Data on trends in antimicrobial resistance and decreased susceptibility in gonococcal infection in England and Wales are provided by the Gonococcal Resistance to Antimicrobials Surveillance Programme (GRASP). GRASP reports are published annually and a GRASP protocol is available.

Please email grasp.enquiries@ukhsa.gov.uk for any queries relating to gonorrhoea treatment failure and Neisseria gonorrhoeae ceftriaxone resistance. UKHSA guidance is available on managing incidents of ceftriaxone-resistant N. gonorrhoeae in England

Possible cases of gonorrhoea ceftriaxone treatment failure should be reported to the UK Health Security Agency (UKHSA) via the HIV and STI Data Exchange

Links to other international surveillance programmes

• ECDC Euro-GASP latest outputs
• WHO Gonococcal Antimicrobial Surveillance Programme (GASP)
• Gonococcal Isolate Surveillance Project (GISP)

---

Surveillance of antimicrobial resistance in Mycoplasma genitalium in England is conducted through the M. genitalium Antimicrobial Resistance Surveillance (MARS) Programme. MARS reports are published annually. 

Possible cases of Mgen treatment failure with third-line treatments should be reported to the UK Health Security Agency (UKHSA) via the HIV and STI Data Exchange

---